A detailed history of Bard Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bard Financial Services, Inc. holds 69,255 shares of ABBV stock, worth $12.5 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
69,255
Previous 24,430 183.48%
Holding current value
$12.5 Million
Previous $4.82 Million 183.5%
% of portfolio
1.63%
Previous 1.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$163.84 - $199.33 $7.34 Million - $8.93 Million
44,825 Added 183.48%
69,255 $13.7 Million
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $8.25 Million - $10 Million
-50,325 Reduced 67.32%
24,430 $4.82 Million
Q2 2024

Jul 09, 2024

SELL
$154.79 - $180.76 $54,176 - $63,266
-350 Reduced 0.47%
74,755 $12.8 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $198,144 - $223,156
1,440 Added 1.95%
75,105 $11.6 Million
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $92,177 - $106,708
690 Added 0.95%
73,665 $11 Million
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $132,510 - $164,900
-1,000 Reduced 1.35%
72,975 $9.83 Million
Q1 2023

Apr 26, 2023

SELL
$144.61 - $166.54 $36,152 - $41,635
-250 Reduced 0.34%
73,975 $11.8 Million
Q4 2022

Jan 25, 2023

SELL
$138.31 - $165.87 $20,054 - $24,051
-145 Reduced 0.19%
74,225 $12 Million
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $33,552 - $38,482
-250 Reduced 0.34%
74,370 $9.98 Million
Q2 2022

Jul 06, 2022

SELL
$137.62 - $174.96 $68,810 - $87,480
-500 Reduced 0.67%
74,620 $11.4 Million
Q1 2022

Apr 13, 2022

BUY
$131.98 - $163.75 $26,395 - $32,750
200 Added 0.27%
75,120 $12.2 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $145,030 - $183,505
1,350 Added 1.83%
74,920 $10.1 Million
Q3 2021

Oct 15, 2021

SELL
$106.4 - $120.78 $93,100 - $105,682
-875 Reduced 1.18%
73,570 $7.94 Million
Q2 2021

Jul 13, 2021

BUY
$105.21 - $117.21 $60,495 - $67,395
575 Added 0.78%
74,445 $8.39 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $332,986 - $366,578
-3,255 Reduced 4.22%
73,870 $7.99 Million
Q4 2020

Mar 26, 2021

BUY
$80.49 - $108.67 $6.21 Million - $8.38 Million
77,125 New
77,125 $8.26 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bard Financial Services, Inc. Portfolio

Follow Bard Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.